Katz Brian S, McMullan Jason T, Sucharew Heidi, Adeoye Opeolu, Broderick Joseph P
From the Department of Neurology (B.S.K., J.P.B.) and Department of Emergency Medicine (J.T.M., O.A.), University of Cincinnati, College of Medicine, OH; and Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, OH (H.S.).
Stroke. 2015 Jun;46(6):1508-12. doi: 10.1161/STROKEAHA.115.008804. Epub 2015 Apr 21.
We derived and validated the Cincinnati Prehospital Stroke Severity Scale (CPSSS) to identify patients with severe strokes and large vessel occlusion (LVO).
CPSSS was developed with regression tree analysis, objectivity, anticipated ease in administration by emergency medical services personnel and the presence of cortical signs. We derived and validated the tool using the 2 National Institute of Neurological Disorders and Stroke (NINDS) tissue-type plasminogen activator Stroke Study trials and Interventional Management of Stroke III (IMS III) Trial cohorts, respectively, to predict severe stroke (National Institutes of Health Stroke Scale [NIHSS]≥15) and LVO. Standard test characteristics were determined and receiver operator curves were generated and summarized by the area under the curve.
CPSSS score ranges from 0 to 4; composed and scored by individual NIHSS items: 2 points for presence of conjugate gaze (NIHSS≥1); 1 point for presence of arm weakness (NIHSS≥2); and 1 point for presence abnormal level of consciousness commands and questions (NIHSS level of consciousness≥1 each). In the derivation set, CPSSS had an area under the curve of 0.89; score≥2 was 89% sensitive and 73% specific in identifying NIHSS≥15. Validation results were similar with an area under the curve of 0.83; score≥2 was 92% sensitive, 51% specific, a positive likelihood ratio of 3.3, and a negative likelihood ratio of 0.15 in predicting severe stroke. For 222 of 303 IMS III subjects with LVO, CPSSS had an area under the curve of 0.67; a score≥2 was 83% sensitive, 40% specific, positive likelihood ratio of 1.4, and negative likelihood ratio of 0.4 in predicting LVO.
CPSSS can identify stroke patients with NIHSS≥15 and LVO. Prospective prehospital validation is warranted.
我们推导并验证了辛辛那提院前卒中严重程度量表(CPSSS),以识别重症卒中和大血管闭塞(LVO)患者。
CPSSS通过回归树分析、客观性、急诊医疗服务人员预期易于实施以及存在皮质体征而开发。我们分别使用两项美国国立神经疾病和中风研究所(NINDS)组织型纤溶酶原激活剂卒中研究试验以及中风介入管理III(IMS III)试验队列来推导和验证该工具,以预测重症卒中(美国国立卫生研究院卒中量表[NIHSS]≥15)和LVO。确定了标准测试特征,并生成了受试者操作曲线,并通过曲线下面积进行总结。
CPSSS评分范围为0至4分;由各个NIHSS项目组成并评分:存在共轭凝视(NIHSS≥1)得2分;存在手臂无力(NIHSS≥2)得1分;存在意识指令和问题异常水平(每个意识水平NIHSS≥1)得1分。在推导集中,CPSSS的曲线下面积为0.89;评分≥2在识别NIHSS≥15时敏感性为89%,特异性为73%。验证结果相似,曲线下面积为0.83;评分≥2在预测重症卒中时敏感性为92%,特异性为51%,阳性似然比为3.3,阴性似然比为0.15。对于IMS III试验中303例LVO受试者中的222例,CPSSS的曲线下面积为0.67;评分≥2在预测LVO时敏感性为83%,特异性为40%,阳性似然比为1.4,阴性似然比为0.4。
CPSSS可识别NIHSS≥15和LVO的卒中患者。有必要进行前瞻性院前验证。